Skip to main content
Have a personal or library account? Click to login
Establishing a process for the use of hydroxyurea in pediatric sickle cell patients in Angola Cover

Establishing a process for the use of hydroxyurea in pediatric sickle cell patients in Angola

Open Access
|Aug 2016

Authors

R. Beaty

philip.landrigan@mssm.edu

Department of Pharmacy, Texas Children’s Hospital

G. Airewele

philip.landrigan@mssm.edu

Texas Children’s Cancer and Hematology Centers; Baylor College of Medicine

D. Nirenberg

philip.landrigan@mssm.edu

Texas Children’s Cancer and Hematology Centers; Baylor College of Medicine

M.P. Noli

philip.landrigan@mssm.edu

Baylor College of Medicine; Baylor International Pediatrics Aids Initiative

S. Kahan

philip.landrigan@mssm.edu

Baylor College of Medicine; Baylor International Pediatrics Aids Initiative

E. Ishigami

philip.landrigan@mssm.edu

Texas Children’s Cancer and Hematology Centers

M. Cubbage

philip.landrigan@mssm.edu

Texas Children’s Cancer and Hematology Centers

W. Zhang

philip.landrigan@mssm.edu

Texas Children’s Cancer and Hematology Centers

K. Wilson-Lewis

philip.landrigan@mssm.edu

Texas Children’s Cancer and Hematology Centers
Language: English
Published on: Aug 20, 2016
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2016 R. Beaty, G. Airewele, D. Nirenberg, M.P. Noli, S. Kahan, E. Ishigami, M. Cubbage, W. Zhang, K. Wilson-Lewis, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.